| |
|
|
|
Iain Ross
Mr. Ross, a director of the company, has broad experience in the
pharmaceutical and biotechnology sector. Mr. Ross held senior positions in
Sandoz
(Novartis), Fisons,
and Roche. In 1991, he joined the Board of Directors of Celltech
Group plc and was CEO
of Celltech Biologics from 1991-1995. From 1995 through 2000 he was
CEO of Quadrant Healthcare, which he took public in 1998, merged
with Andaris Ltd.
in 1999 and sold to Elan in 2000. In 2001/2002 Mr Ross was responsible
for the operational and financial turn-around of Allergy Therapeutics
Ltd. Currently
Mr. Ross is Chairman and director of a number of life sciences companies
including Biomer Technologies Ltd, Metabometrix Ltd and Eden Biopharma
Group Ltd. In
addition he is an advisor to a number of venture funds.
|
|
|
|
|
